Luke van der Nest, our Head of Business Development, recently chatted to the teams at eNCA and Channel Africa about the global cannabis markets, the increasing demand for pharmaceutical-grade products, and where MG Health fits into all of this post expansion.
It is no secret that Africa, as a continent, possesses substantial potential to capture a significant share of the global medicinal cannabis industry, given proper management and regulatory oversight. Luke’s insights shed further light on how the pristine environment of the Maluti mountains serves as a prominent exemplar of this potential, continuously contributing to the production of MG Health’s pure, non-irradiated, pharmaceutical-grade products. 🌱
Check it out: